Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Clin Lipidol. 2020 Jul 3;14(5):695–706.e4. doi: 10.1016/j.jacl.2020.06.010

Supplement Table 4.

Association of Lp(a) with MI and stroke in multivariate analyses with polynomials and interactions included for the entire population and by sex or race/ethnicity at various dichotomous cut-points

Covariate MI Stroke
OR (95% CI) P-value OR (95% CI) P-value
Entire population - - - -
 ≥30 mg/dL 1.63 (1.09, 2.45) .02 0.89 (0.58, 1.37) .61
 ≥50 mg/dL 2.22 (1.36, 3.61) .001 1.26 (0.77, 2.06) .37
 ≥70 mg/dL 3.06 (1.51, 6.21) .002 1.80 (0.88, 3.70) .11
 ≥90 mg/dL 3.04 (1.20, 7.69) .02 2.12 (0.83, 5.39) .11
Male - - - -
 ≥30 mg/dL 1.75 (1.00, 3.09) .052 0.84 (0.46, 1.54) .57
 ≥50 mg/dL 2.96 (1.47, 5.95) .002 1.01 (0.50, 2.06) .98
 ≥70 mg/dL 4.27 (1.58, 11.53) .004 1.18 (0.36, 3.85) .78
 ≥90 mg/dL 4.03 (1.06, 15.3) .04 1.03 (0.46, 2.30) .95
Female - - - -
 ≥30 mg/dL 1.42 (0.87, 2.33) .16 0.93 (0.49, 1.75) .81
 ≥50 mg/dL 1.46 (0.84, 2.54) .18 1.42 (0.70, 2.87) .33
 ≥70 mg/dL 1.81 (0.80, 4.10) .16 2.36 (0.93, 6.03) .07
 ≥90 mg/dL 1.95 (0.63, 6.07) .25 3.14 (0.89, 11.0) .08
Non-Hispanic white - - - -
 ≥30 mg/dL 1.94 (1.22, 3.08) .005 0.98 (0.57, 1.71) .96
 ≥50 mg/dL 2.95 (1.68, 5.21) <.001 1.34 (0.68, 2.66) .39
 ≥70 mg/dL 4.99 (2.17, 11.49) <.001 2.63 (0.99, 6.98) .052
 ≥90 mg/dL 4.93 (1.60, 15.23) .006 3.29 (0.93, 11.64) .06
Non-Hispanic black - - - -
 ≥30 mg/dL 0.70 (0.41, 1.22) .21 1.09 (0.57, 2.11) .79
 ≥50 mg/dL 0.65 (0.37, 1.14) .13 1.38 (0.76, 2.54) .29
 ≥70 mg/dL 0.84 (0.44, 1.60) .60 1.33 (0.65, 2.73) .44
 ≥90 mg/dL 0.88 (0.34, 1.77) .54 0.93 (0.42, 2.22) .93
Mexican American - - - -
 ≥30 mg/dL 3.59 (1.65, 7.82) .001 1.10 (0.42, 2.88) .85
 ≥50 mg/dL 8.04 (3.52, 18.36) <.001 1.36(0.31, 5.88) .68
 ≥70 mg/dL 3.25 (0.63, 16.74) .16 0.37 (0.05, 2.59) .31
 ≥90 mg/dL 8.09 (0.77, 85.10) .08 0.79 (0.11, 5.57) .82

CI, confidence interval; Lp(a), lipoprotein (a); MI, myocardial infarction; OR, odds ratio